This page follows insider dealings at Merus Labs International Inc. as filed with SEDI. Nothing new has been filed by managers of Merus Labs International Inc. in twelve months, the latest record being from 26 January 2018.
Since 2016, the database holds 12 purchases and no sales by insiders of the company.
Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
25 of 42 declarations
Merus Labs International Inc. is a company focused on the development and commercialization of pharmaceutical products. It is listed on the XTSE market.